Efficacy of Black seed (Nigella sativa) in the management of Type 2 Diabetes
Not Applicable
- Conditions
- Nutritional, Metabolic, Endocrine
- Registration Number
- PACTR202310875852492
- Lead Sponsor
- African ai Japan project JICA JKUAT PAUSTI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
All participants with Type 2 diabetes attending care at Gatundu Level 5 Hospital Non-communicable Disease Center who consented to participate and signed a written informed consent.
Exclusion Criteria
Type 2 diabetes patient attending care at Gatundu Level 5 Hospital Non-communicable Disease Center WHO HAD COMPLICATION SUCH AS RENAL FAILURE, STROKE.
Those who did not consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method mean change in HbA1C 3 months post intervention
- Secondary Outcome Measures
Name Time Method Mean changes in Lipid profile--Triglycerides, total cholesterol, high density lipo-protein and low density lipo-protein post intervention;mean changes in Tumor necrotic factor post intervention;mean change in antioxidant factor-vitamin C and glutathione level post intervention